These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 19751275

  • 1. Lipoxin A(4) metabolites/analogues from two commercial sources have no effects on TNF-alpha-mediated priming or activation through the neutrophil formyl peptide receptors.
    Forsman H, Dahlgren C.
    Scand J Immunol; 2009 Oct; 70(4):396-402. PubMed ID: 19751275
    [Abstract] [Full Text] [Related]

  • 2. Stable formyl peptide receptor agonists that activate the neutrophil NADPH-oxidase identified through screening of a compound library.
    Forsman H, Kalderén C, Nordin A, Nordling E, Jensen AJ, Dahlgren C.
    Biochem Pharmacol; 2011 Feb 01; 81(3):402-11. PubMed ID: 21095183
    [Abstract] [Full Text] [Related]

  • 3. The FPR2-specific ligand MMK-1 activates the neutrophil NADPH-oxidase, but triggers no unique pathway for opening of plasma membrane calcium channels.
    Karlsson J, Stenfeldt AL, Rabiet MJ, Bylund J, Forsman HF, Dahlgren C.
    Cell Calcium; 2009 May 01; 45(5):431-8. PubMed ID: 19282028
    [Abstract] [Full Text] [Related]

  • 4. Lack of activity of 15-epi-lipoxin A₄ on FPR2/ALX and CysLT1 receptors in interleukin-8-driven human neutrophil function.
    Planagumà A, Domenech T, Jover I, Ramos I, Sentellas S, Malhotra R, Miralpeix M.
    Clin Exp Immunol; 2013 Aug 01; 173(2):298-309. PubMed ID: 23607720
    [Abstract] [Full Text] [Related]

  • 5. What formyl peptide receptors, if any, are triggered by compound 43 and lipoxin A4?
    Forsman H, Önnheim K, Andreasson E, Dahlgren C.
    Scand J Immunol; 2011 Sep 01; 74(3):227-234. PubMed ID: 21535079
    [Abstract] [Full Text] [Related]

  • 6. The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8.
    Fu H, Bylund J, Karlsson A, Pellmé S, Dahlgren C.
    Immunology; 2004 Jun 01; 112(2):201-10. PubMed ID: 15147563
    [Abstract] [Full Text] [Related]

  • 7. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
    Stenfeldt AL, Karlsson J, Wennerås C, Bylund J, Fu H, Dahlgren C.
    Biochem Pharmacol; 2007 Oct 01; 74(7):1050-6. PubMed ID: 17692291
    [Abstract] [Full Text] [Related]

  • 8. The two neutrophil members of the formylpeptide receptor family activate the NADPH-oxidase through signals that differ in sensitivity to a gelsolin derived phosphoinositide-binding peptide.
    Fu H, Björkman L, Janmey P, Karlsson A, Karlsson J, Movitz C, Dahlgren C.
    BMC Cell Biol; 2004 Dec 29; 5(1):50. PubMed ID: 15625007
    [Abstract] [Full Text] [Related]

  • 9. Changes in the ratio between FPR and FPRL1 triggered superoxide production in human neutrophils-a tool in analysing receptor specific events.
    Fu H, Karlsson J, Björkman L, Stenfeldt AL, Karlsson A, Bylund J, Dahlgren C.
    J Immunol Methods; 2008 Feb 29; 331(1-2):50-8. PubMed ID: 18166194
    [Abstract] [Full Text] [Related]

  • 10. Thermal injury-induced priming effect of neutrophil is TNF-alpha and P38 dependent.
    Chen LW, Huang HL, Lee IT, Hsu CM, Lu PJ.
    Shock; 2006 Jul 29; 26(1):69-76. PubMed ID: 16783201
    [Abstract] [Full Text] [Related]

  • 11. PKC-delta controls the fMLF-induced overproduction of superoxide by neutrophils.
    Matron C, Chakravarti A, Allaeys I, Poubelle PE.
    Free Radic Biol Med; 2010 Jan 15; 48(2):207-15. PubMed ID: 19854263
    [Abstract] [Full Text] [Related]

  • 12. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils.
    Bae YS, Park JC, He R, Ye RD, Kwak JY, Suh PG, Ho Ryu S.
    Mol Pharmacol; 2003 Sep 15; 64(3):721-30. PubMed ID: 12920210
    [Abstract] [Full Text] [Related]

  • 13. Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1/lipoxin A4 receptor: implications for resolution of inflammation.
    El Kebir D, József L, Filep JG.
    J Leukoc Biol; 2008 Sep 15; 84(3):600-6. PubMed ID: 18495783
    [Abstract] [Full Text] [Related]

  • 14. Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A₄.
    Hanson J, Ferreirós N, Pirotte B, Geisslinger G, Offermanns S.
    Biochem Pharmacol; 2013 Jun 15; 85(12):1795-802. PubMed ID: 23643932
    [Abstract] [Full Text] [Related]

  • 15. The proteolytically stable peptidomimetic Pam-(Lys-βNSpe)6-NH2 selectively inhibits human neutrophil activation via formyl peptide receptor 2.
    Skovbakke SL, Heegaard PM, Larsen CJ, Franzyk H, Forsman H, Dahlgren C.
    Biochem Pharmacol; 2015 Jan 15; 93(2):182-95. PubMed ID: 25462815
    [Abstract] [Full Text] [Related]

  • 16. Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor.
    Stenfeldt AL, Karlsson J, Wennerås C, Bylund J, Fu H, Dahlgren C.
    Inflammation; 2007 Dec 15; 30(6):224-9. PubMed ID: 17687636
    [Abstract] [Full Text] [Related]

  • 17. Desensitization of formyl peptide receptors is abolished in calcium ionophore-primed neutrophils: an association of the ligand-receptor complex to the cytoskeleton is not required for a rapid termination of the NADPH-oxidase response.
    Liu L, Harbecke O, Elwing H, Follin P, Karlsson A, Dahlgren C.
    J Immunol; 1998 Mar 01; 160(5):2463-8. PubMed ID: 9498791
    [Abstract] [Full Text] [Related]

  • 18. Structural changes of the ligand and of the receptor alters the receptor preference for neutrophil activating peptides starting with a formylmethionyl group.
    Forsman H, Winther M, Gabl M, Skovbakke SL, Boulay F, Rabiet MJ, Dahlgren C.
    Biochim Biophys Acta; 2015 Jan 01; 1853(1):192-200. PubMed ID: 25447672
    [Abstract] [Full Text] [Related]

  • 19. Neutrophil NADPH-oxidase activation by an annexin AI peptide is transduced by the formyl peptide receptor (FPR), whereas an inhibitory signal is generated independently of the FPR family receptors.
    Karlsson J, Fu H, Boulay F, Dahlgren C, Hellstrand K, Movitz C.
    J Leukoc Biol; 2005 Sep 01; 78(3):762-71. PubMed ID: 15951351
    [Abstract] [Full Text] [Related]

  • 20. The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor.
    Dahlgren C, Christophe T, Boulay F, Madianos PN, Rabiet MJ, Karlsson A.
    Blood; 2000 Mar 01; 95(5):1810-8. PubMed ID: 10688842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.